Biogen MS Pill Tecfidera Gains U.S. Approval

Biogen MS Pill Tecfidera Gains U.S. Approval Play

March 27 (Bloomberg) -- Biogen Idec, the maker of multiple sclerosis drugs Avonex and Tysabri, won U.S. approvalfor its first pill for the disease, Tecfidera. Adam Johnson reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus